CCM
Copernicus Capital Management Portfolio holdings
AUM
$8.26M
This Quarter Return
+39.9%
1 Year Return
+37.91%
3 Year Return
+125.34%
5 Year Return
–
10 Year Return
–
AUM
$91.2M
AUM Growth
+$91.2M
(+10%)
Cap. Flow
-$1.59M
Cap. Flow
% of AUM
-1.75%
Top 10 Holdings %
Top 10 Hldgs %
79.32%
Holding
27
New
13
Increased
1
Reduced
4
Closed
9
Top Buys
| 1 |
AbbVie
ABBV
|
$10.8M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$9.54M |
| 3 |
Amgen
AMGN
|
$7.78M |
| 4 |
IQVIA
IQV
|
$5.68M |
| 5 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$5.51M |
Top Sells
| 1 |
Cigna
CI
|
$9.7M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$8.75M |
| 3 |
CVS Health
CVS
|
$7.71M |
| 4 |
McKesson
MCK
|
$6.9M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$6.57M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Thermo Fisher Scientific
TMO
$186B
| – | – |
-18,896
| Closed | -$5.36M |
|
27
Tandem Diabetes Care
TNDM
$845M
| – | – |
-42,685
| Closed | -$2.75M |
|